Compare PAHC & AIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PAHC | AIN |
|---|---|---|
| Founded | 1946 | 1895 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Textiles |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.5B |
| IPO Year | 2014 | 1987 |
| Metric | PAHC | AIN |
|---|---|---|
| Price | $40.78 | $50.18 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 4 | 4 |
| Target Price | $31.25 | ★ $64.25 |
| AVG Volume (30 Days) | 273.3K | ★ 427.4K |
| Earning Date | 02-04-2026 | 11-05-2025 |
| Dividend Yield | 1.18% | ★ 2.23% |
| EPS Growth | ★ 288.74 | N/A |
| EPS | ★ 1.67 | N/A |
| Revenue | ★ $1,399,676,000.00 | $1,148,512,000.00 |
| Revenue This Year | $15.34 | N/A |
| Revenue Next Year | $3.28 | N/A |
| P/E Ratio | $24.30 | ★ N/A |
| Revenue Growth | ★ 33.72 | N/A |
| 52 Week Low | $16.16 | $41.15 |
| 52 Week High | $46.42 | $83.65 |
| Indicator | PAHC | AIN |
|---|---|---|
| Relative Strength Index (RSI) | 48.75 | 51.55 |
| Support Level | $39.39 | $49.70 |
| Resistance Level | $41.62 | $53.88 |
| Average True Range (ATR) | 1.66 | 1.53 |
| MACD | -0.02 | 0.45 |
| Stochastic Oscillator | 63.50 | 49.73 |
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
Albany International Corp is principally engaged in processing textiles and materials. The company consists of two business segments, the machine clothing segment, which produces and provides custom-designed fabrics and belts for the production in the paper, nonwovens, and other process industries; and the Albany engineered composites segment, which offers engineered composite parts for the aerospace and defensive industries. The machine clothing segment contributes to the majority of the company's total revenue. The company has an operation and generates revenue from the United States, Switzerland, Brazil, China, Mexico, France, and other areas.